chartexchange

Aura Biosciences Reports Third Quarter 2026 Financial Results and Recent Business Highlights

GlobeNewswire Inc. | Nov 9, 2026 7:00 AM EST

Phase 3 CoMpass trial on track for topline data in 2H 2027; all participants have completed treatment visits

Read original article